138023-40-2

Usage

Explanation

The molecular formula represents the number of atoms of each element present in a molecule. In this case, the compound has 8 carbon (C), 8 hydrogen (H), and 1 iodine (I) atoms.

Explanation

1,4-Ethanoquinoxaline, 2,3-dihydro-5-iodois derived from the parent compound ethanoquinoxaline, which is a fused-ring system of two six-membered nitrogen-containing heterocycles.

Explanation

The compound contains a dihydro-5-iodo group, which means it has two hydrogen atoms added to the 2,3-positions and an iodine atom at the 5-position of the quinoxaline ring.

Explanation

Due to its unique structure, 1,4-Ethanoquinoxaline, 2,3-dihydro-5-iodois used as a starting material or building block in the synthesis of new drug candidates for various therapeutic applications.

Explanation

Studies have shown that 1,4-Ethanoquinoxaline, 2,3-dihydro-5-iodo- may have antimicrobial properties, which could be useful in the development of new antibiotics or antifungal agents.

Explanation

Research has indicated that 1,4-Ethanoquinoxaline, 2,3-dihydro-5-iodomay possess antitumor properties, making it a potential candidate for the development of new cancer treatments.

Explanation

The presence of the iodine atom in the compound makes it suitable for radiochemical labeling studies, which are important in the field of nuclear medicine for diagnostic and therapeutic purposes.

Explanation

1,4-Ethanoquinoxaline, 2,3-dihydro-5-iodohas various potential applications in the fields of medicine, such as drug development and cancer research, as well as in chemical research for the synthesis of new compounds and materials.

Derivative of Ethanoquinoxaline

Yes

Dihydro-5-iodo Group

Present

Pharmaceutical Research

Building block for potential drug candidates

Antimicrobial Properties

Potentially effective

Antitumor Properties

Potentially effective

Radiochemical Labeling

Useful in nuclear medicine

Applications

Medicine and chemical research